This CRY PE ratio history page last updated 11/8/2021
Period | Price | Adj. EPS | TTM | PE |
Q3 2021 11/4/2021 | 21.21 | -0.03 | 0.32 | 66.3 | Q2 2021 7/29/2021 | 27.41 | 0.12 | 0.48 | 57.1 | Q1 2021 4/29/2021 | 23.49 | 0.03 | 0.34 | 69.1 | Q4 2020 2/11/2021 | 25.41 | 0.20 | 0.23 | 110.5 | Q3 2020 11/4/2020 | 18.29 | 0.13 | 0.13 | 140.7 | Q2 2020 7/30/2020 | 18.90 | -0.02 | 0.06 | 315.0 | Q1 2020 4/30/2020 | 22.33 | -0.08 | 0.19 | 117.5 | Q4 2019 2/13/2020 | 30.30 | 0.10 | 0.31 | 97.7 | Q3 2019 10/30/2019 | 23.81 | 0.06 | 0.26 | 91.6 | Q2 2019 7/30/2019 | 30.49 | 0.11 | 0.28 | 108.9 | Q1 2019 4/30/2019 | 30.66 | 0.04 | 0.27 | 113.6 | Q4 2018 2/13/2019 | 30.24 | 0.05 | 0.25 | 121.0 | Q3 2018 10/31/2018 | 30.98 | 0.08 | 0.31 | 99.9 | Q2 2018 8/6/2018 | 29.60 | 0.10 | 0.31 | 95.5 | Q1 2018 5/2/2018 | 23.10 | 0.02 | 0.33 | 70.0 | Q4 2017 3/7/2018 | 19.90 | 0.11 | 0.40 | 49.7 | Q3 2017 10/30/2017 | 20.10 | 0.08 | 0.41 | 49.0 | Q2 2017 7/24/2017 | 19.70 | 0.12 | 0.46 | 42.8 | Q1 2017 4/26/2017 | 16.75 | 0.09 | 0.47 | 35.6 | Q4 2016 2/15/2017 | 19.55 | 0.12 | 0.48 | 40.7 | Q3 2016 10/26/2016 | 16.70 | 0.13 | 0.49 | 34.1 | Q2 2016 7/25/2016 | 12.02 | 0.13 | 0.46 | 26.1 | Q1 2016 4/27/2016 | 12.07 | 0.10 | 0.36 | 33.5 | Q4 2015 2/16/2016 | 9.79 | 0.13 | 0.30 | 32.6 | Q3 2015 10/27/2015 | 10.46 | 0.10 | 0.21 | 49.8 | Q2 2015 7/28/2015 | 10.99 | 0.03 | 0.19 | 57.8 | Q1 2015 4/28/2015 | 10.78 | 0.04 | 0.24 | 44.9 | Q4 2014 2/17/2015 | 10.71 | 0.04 | 0.24 | 44.6 | Q3 2014 10/28/2014 | 10.41 | 0.08 | 0.51 | 20.4 | Q2 2014 7/24/2014 | 10.03 | 0.08 | 0.55 | 18.2 | Q1 2014 4/29/2014 | 9.28 | 0.04 | 0.55 | 16.9 | Q4 2013 2/20/2014 | 9.41 | 0.31 | 0.59 | 15.9 | Q3 2013 10/29/2013 | 9.00 | 0.12 | 0.36 | 25.0 | Q2 2013 7/25/2013 | 7.23 | 0.08 | 0.32 | 22.6 | Q1 2013 4/30/2013 | 6.00 | 0.08 | 0.34 | 17.6 | Q4 2012 2/14/2013 | 6.20 | 0.08 | NA | NA | Q3 2012 10/30/2012 | NA | 0.08 | NA | NA | Q2 2012 7/31/2012 | 5.56 | 0.10 | NA | NA |
|
Period | Price | Adj. EPS | Annualized | PE |
Q3 2021 11/4/2021 | 21.21 | -0.03 | -0.12 | NA | Q2 2021 7/29/2021 | 27.41 | 0.12 | 0.48 | 57.1 | Q1 2021 4/29/2021 | 23.49 | 0.03 | 0.12 | 195.8 | Q4 2020 2/11/2021 | 25.41 | 0.20 | 0.80 | 31.8 | Q3 2020 11/4/2020 | 18.29 | 0.13 | 0.52 | 35.2 | Q2 2020 7/30/2020 | 18.90 | -0.02 | -0.08 | NA | Q1 2020 4/30/2020 | 22.33 | -0.08 | -0.32 | NA | Q4 2019 2/13/2020 | 30.30 | 0.10 | 0.40 | 75.8 | Q3 2019 10/30/2019 | 23.81 | 0.06 | 0.24 | 99.2 | Q2 2019 7/30/2019 | 30.49 | 0.11 | 0.44 | 69.3 | Q1 2019 4/30/2019 | 30.66 | 0.04 | 0.16 | 191.6 | Q4 2018 2/13/2019 | 30.24 | 0.05 | 0.20 | 151.2 | Q3 2018 10/31/2018 | 30.98 | 0.08 | 0.32 | 96.8 | Q2 2018 8/6/2018 | 29.60 | 0.10 | 0.40 | 74.0 | Q1 2018 5/2/2018 | 23.10 | 0.02 | 0.08 | 288.8 | Q4 2017 3/7/2018 | 19.90 | 0.11 | 0.44 | 45.2 | Q3 2017 10/30/2017 | 20.10 | 0.08 | 0.32 | 62.8 | Q2 2017 7/24/2017 | 19.70 | 0.12 | 0.48 | 41.0 | Q1 2017 4/26/2017 | 16.75 | 0.09 | 0.36 | 46.5 | Q4 2016 2/15/2017 | 19.55 | 0.12 | 0.48 | 40.7 | Q3 2016 10/26/2016 | 16.70 | 0.13 | 0.52 | 32.1 | Q2 2016 7/25/2016 | 12.02 | 0.13 | 0.52 | 23.1 | Q1 2016 4/27/2016 | 12.07 | 0.10 | 0.40 | 30.2 | Q4 2015 2/16/2016 | 9.79 | 0.13 | 0.52 | 18.8 | Q3 2015 10/27/2015 | 10.46 | 0.10 | 0.40 | 26.2 | Q2 2015 7/28/2015 | 10.99 | 0.03 | 0.12 | 91.6 | Q1 2015 4/28/2015 | 10.78 | 0.04 | 0.16 | 67.4 | Q4 2014 2/17/2015 | 10.71 | 0.04 | 0.16 | 66.9 | Q3 2014 10/28/2014 | 10.41 | 0.08 | 0.32 | 32.5 | Q2 2014 7/24/2014 | 10.03 | 0.08 | 0.32 | 31.3 | Q1 2014 4/29/2014 | 9.28 | 0.04 | 0.16 | 58.0 | Q4 2013 2/20/2014 | 9.41 | 0.31 | 1.24 | 7.6 | Q3 2013 10/29/2013 | 9.00 | 0.12 | 0.48 | 18.8 | Q2 2013 7/25/2013 | 7.23 | 0.08 | 0.32 | 22.6 | Q1 2013 4/30/2013 | 6.00 | 0.08 | 0.32 | 18.8 | Q4 2012 2/14/2013 | 6.20 | 0.08 | 0.32 | 19.4 | Q3 2012 10/30/2012 | NA | 0.08 | 0.32 | NA | Q2 2012 7/31/2012 | 5.56 | 0.10 | 0.40 | 13.9 |
|
On this page we presented the CRY PE Ratio History information for Cryolife' stock.
The average CRY PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 64.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CRY PE ratio history based on this TTM earnings result method is 67.2. Note: any PE calculations involving negative earnings were discarded as not meaningful.
Let's now compare this CRY PE ratio history result, against the recent PE: when this page was posted on 11/5/2021, the most recent closing price for CRY had been 22.18, and the most recent quarterly earnings result, annualized, was 0.48. Meanwhile, the most recent TTM earnings summed to 0.32. From these numbers, we calculate the recent CRY PE on 11/5/2021 based on annualized quarterly EPS was 46.2. Based on CRY's history, that recent PE is low relative to the historical average, with the recent PE 28.0% lower than the historical average PE across our data set for Cryolife. Looking at the recent CRY PE on 11/5/2021 based on TTM EPS, we calculate the ratio at 69.3. Based on CRY's history, that recent PE is elevated relative to the historical average, with the recent PE 3.1% higher than the historical average PE across our Cryolife data set with TTM EPS used in the calculation at each period.
Another interesting CRY PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for CRY, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for CRY, we start with the past four EPS numbers and we first sort them from lowest to highest: -0.03, 0.03, 0.12, and 0.20. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.03 and 0.12 — which gives us the median of 0.07. Basically the way to think about this 0.07 number is this: for the trailing four earnings reports, 0.07 marks the "middle ground" number where CRY has reported a value higher than 0.07 half the time, and has reported a value lower than 0.07 half the time. Annualizing that median value then gets us to 0.28/share, which we use as the denominator in our next PE calculation. With 22.18 as the numerator (as of 11/5/2021), the calculation is then 22.18 / 0.28 = 79.2 as the CRY PE ratio as of 11/5/2021, based on that annualized median value we calculated.
For self directed investors doing their due diligence on CRY or any other given stock, valuation analysis for CRY
can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can
help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios
justify the current stock market value.
That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate
Cryolife PE ratio history — or the PE history for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for
next earnings dates and also historical earnings surprises history for CRY. Thanks for visiting, and the next
time you need to research CRY PE Ratio History or the PE ratio history for another stock, we hope our site
will come to mind as your go-to PE ratio history research resource of choice.